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GlutathioneAbstract Background: Anesthesia and surgery starts a series of stress responses in the body. Sub-
sequently, loss of normal anabolic actions of insulin and development of insulin resistance occur.
Resulting hyperglycemia has been considered by an evidence based study as a risk factor for peri-
operative morbidity and mortality. We tested whether a single preoperative dose of alanyl-gluta-
mine would prevent such responses in addition to maintaining glutathione level; an important
factor for maintaining cellular redox potential.
Methods: A total of 40 cancer patients were enrolled in this study who received an infusions of
500 ml of Normal Saline started an hour before surgery and continued throughout the surgery.
The Dipeptiven group (20 patients): 2 ml Dipeptiven/kg were added to saline, while the control
group (20 patients): nothing was added to saline. Blood samples were taken a preoperative sample
and two postoperative samples (immediately after immergence from anesthesia and 24 h after sur-
gery). These samples were analyzed for plasma glucose, plasma insulin to calculate insulin resistance
by HOMA test. Plasma reduced glutathione level was also analyzed in the same time points.
Results: We found that insulin resistance and glucose level were less in the tested time points in the
Dipeptiven group of patients when compared with the control group. Furthermore, plasma gluta-
thione level was higher in the Dipeptiven group than the control group.
320 G.M.N. Bashandy et al.Conclusion: Preoperative alanyl-glutamine is helpful in amelioration of insulin resistance and
improvement of plasma glutathione levels in the early postoperative period.
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Achieving ideal perioperative glycemic control is a challenging
task, and it is considered an important goal in all enhanced
recovery after surgery programs (ERAS) [1]. Perioperative
hyperglycemia has been identiﬁed by evidence base as a risk
factor for perioperative morbidity and mortality [2]. Preopera-
tive fasting [3], preoperative mechanical bowel preparation
(MBP) [4], surgery and anesthesia start a series of stress re-
sponses [5]. Non-diabetic cancer patients often have disturbed
glucose metabolism. It was shown that every fourth patient
coming for colorectal surgery without known diabetes had
an elevated HbA1c [6].
All those together result in loss of normal anabolic actions
of insulin and the development of insulin resistance which is a
state of decreased biological effect to any given concentration
of insulin [7]. There will be also a state of catabolism with con-
tinuous breakdown of muscle tissue and loss of energy stores
that prolongs the time to recovery [8].
Intensive Insulin Therapy (IIT) protocols and tight glyce-
mic control still have no evidence to support its routine use
in the operating room. Maintaining blood glucose less than
150 mg/dL and reducing its variability may be both safe and
effective. However, still intraoperative insulin therapy research
is lacking and focused mainly on the cardiac surgery popula-
tion [2]. A closed-loop artiﬁcial endocrine pancreas system
has also been tried in the perioperative period [9]. Insulin reg-
ulated diurnal rhythm of metabolism is also lost due to pro-
longed preoperative fasting. Patients present to surgery after
overnight fast in a state of catabolism mainly by effect of glu-
cagon and cortisol [3]. So, preventing the development of insu-
lin resistance by putting the patient in a balanced metabolic
state to be able to take care of glucose control with endoge-
nous insulin release is an ideal solution [1]. This is clinically
important since intravenous insulin with the entailing need
for continual adjustments is usually difﬁcult to manage on reg-
ular surgical wards.
Our primary end point is to prove that a single preoperative
dose of alanyl-glutamine may decrease insulin resistance and
hyperglycemia commonly encountered in the early postopera-
tive period. Glutamine, traditionally considered as a nonessen-
tial amino acid under normal physiological conditions, has
received considerable attention in becoming ‘‘conditionally
indispensable’’ during catabolic states such as major surgery
[10]. Glutamine is one of the immunonutritions or pharma-
conutritions currently under investigation [11]. Recently, there
has been a trend to consider glutamine as a drug and not as a
nutrient [12]. Glutamine has been found to preserve insulin
sensitivity in animal studies [10]. Moreover, glutamine (via glu-
tamate), cysteine, and glycine are the precursor amino acids for
glutathione [13]. So increased insulin resistance results in glu-
cose inﬂux into cells not accustomed to excess glucose like
endothelial cells. The only metabolic pathway for glucose in
such cells is glycolysis. Massive glucose inﬂow to the mito-
chondria will eventually overrun the oxidative capacity, andoxygen free radicals are produced [14]. So proving that
GSH, as an important antioxidant, is preserved in the treated
group is our secondary end point.2. Patients and Methods
2.1. Patients
Patients scheduled for elective abdominal surgery for neoplas-
tic conditions were enrolled in our study. Inclusion criteria
were patients scheduled for open laparotomy, over 18 years
and less than 65 years of age. Patients with known diabetes
mellitus performing surgery for pancreatic neoplasm and pa-
tients on corticosteroids were excluded. Also, patients with se-
vere renal insufﬁciency, severe hepatic insufﬁciency, severe
metabolic acidosis, or known hypersensitivity to any of the
used medications were excluded.
The study design was reviewed and approved by the institu-
tional ethics committee. Written informed consents from pa-
tients were given before inclusion.
2.2. Study design
Forty patients were randomized in our study, where twenty pa-
tients were studied per protocol.
2.2.1. Preoperative Protocol
The nutritional status of all patients was evaluated by BMI.
The day before scheduled operation, only oral ﬂuids were al-
lowed. Both mechanical and chemical bowel preparation have
been done for all patients while in the surgical ward. All pa-
tients underwent at least a standard 8-h preoperative fast.
Patients were randomized to:
1. Control group: All patients in this group received an infu-
sion of 500 ml normal saline. The infusions were started
an hour before surgery and continued through surgery to
be ﬁnished over 3 h.
2. Glutamine group: All patients in this group received an infu-
sion of 2 mL of Dipeptiven/kg body weight (equivalent to
0.4 g N(2)-L-alanyl-L-glutamine/kg body weight). The total
calculated dose of Dipeptiven was added to 500 ml Normal
saline. The rate of infusion was adjusted to be ﬁnished
within 3 h. The infusions were started an hour before sur-
gery and continued through surgery.
At the day of surgery, the patients arrived to the preopera-
tive holding area at 8:00 am. Two 14-gauge IV catheters were
inserted in two upper extremity veins. One IV catheter was
used for Dipeptiven or saline infusion and the other for anes-
thetic drug administration. The patients received morphine
(0.1 mg/kg) IV and Midazolam (2–3 mg IV) as premedication.
In addition, all patients received a single dose of intravenous
antibiotic.
Table 1 Demographics characteristics of the patients.
Control group Glutamine group P value
Age (year) 52.7 ± 1.2 51.9 ± 1.8 0.106
Sex (M/F) 10/10 12/8 0.751
BMI (kg/m2) 26.1 ± 3.1 27.3 ± 2.2 0.166
ASA (I/II) 8/12 7/13 1.000
AST U/L 18.5 ± 3.4 17.4 ± 3.3 0.306
ALT U/L 17.2 ± 2.2 16.6 ± 3.1 0.485
Data presented as mean ± SD.
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General anesthesia was induced with intravenous injection of
propofol (2–2.5 mg/kg) and fentanyl (1–2 mcg/kg) and main-
tained with Sevoﬂurane. Atracurium (0.3–0.6 mg/kg) was used
for muscle relaxation. Standard intraoperative monitors were
used. As per protocol data for circulation, O2 saturation,
blood losses, blood transfusion, and time of surgery were clo-
sely monitored. Crystalloids (Ringer-Acetate) and colloids
(Hydroxyethyl-starch, Voluven) were given as intraoperative
ﬂuid replacement. Blood loss during surgery was replaced with
crystalloids, colloids, and/or blood products. All surgeries
were performed by surgeons with considerable surgical
experience.
After surgery, the patients were transferred to the PACU,
and then, all patients were discharged to the surgical ward.
After emergence from anesthesia, 1000–1500 mL of a 5% glu-
cose solution was administered in all patients until the next
morning. Postoperative NPO was maintained for varying
duration according to the type and extent of the surgical
procedure.
Postoperative analgesia was provided with IV morphine via
PCA pump (loading bolus 40 lg/kg, PCA bolus 25 lg/kg;
lockout 5 min, background infusion 15 lg/kg/h) and paraceta-
mol (Perfalgan 500 mg t.d.s.).
2.3. Analysis
Blood samples were taken, after an overnight fast, in the pre-
operative setting. Two samples were also collected: the ﬁrst
was immediately after emergence from anesthesia and the sec-
ond 24 h after surgery before any oral liquid meal was allowed.
The following estimations were done:
2.3.1. Plasma glucose estimation
Blood was collected by venipuncture into tubes containing
ﬂuoride. Plasma samples were separated by centrifugation at
3000 rpm for 10 min. Plasma glucose was measured by the glu-
cose oxidase method using a commercially available kit sup-
plied by Diamond, Egypt [15].
2.3.2. Plasma insulin estimation
Blood was collected by venipuncture into tubes containing
EDTA. Plasma samples were separated by centrifugation at
3000 rpm for 10 min. Plasma was stored at 20 C until anal-
ysis. Plasma insulin was assayed by a commercially available
Enzyme-linked immunosorbent assay (ELISA) kit supplied
by DRG Diagnostics (GmbH, Germany) [16].
2.3.3. HOMA-IR was calculated as
Insulin (lU/mL by the ELISA technique) · blood glucose
(mg/dL by enzymatic assay)/405 proposed by Matthews
et al. [17].
2.3.4. Reduced glutathione estimation
Plasma glutathione was measured by the Glutathione Assay
Kit supplied by Bio-diagnostic (Egypt, Giza) according to
the manufacturer’s recommendations [18].
Serum ALT, AST, albumin, Na+ and K+ levels were as-
sessed using conventional available kit.2.4. Statistical analysis
Data were computerized and analyzed using the Statistical
Package for the Social Science (SPSS) Version 13. Normality
of the distribution of data was assessed by the Kolmogorov–
Smirnov test. Demographic and hematological data from the
two groups were compared using two-tailed t-test and Chi-
square test as appropriate. Inter- and intra-group differences
among the variables were recorded over time and were ana-
lyzed by using two-way analysis of variance for repeated mea-
sures and paired and unpaired t-tests with Bonferroni post-test
analysis as appropriate. To present the results, mean ± SD
was used and a P< 0.05 was considered statistically
signiﬁcant.
3. Results
This was a prospective randomized controlled clinical study
that was conducted in National Cancer Institute of Egypt
(NCI) between May 2012 and December 2012. Among the
40 patients initially enrolled, only two cases in the control
group were excluded from the study because of massive blood
loss and post operative arrest and were replaced with another
two patients. The forty patients completed the study and had
an uneventful postoperative period.
Data were normally distributed. Demographic characteris-
tics, ASA distribution, and liver function tests are
summarized in Table 1. There were no statistically signiﬁcant
differences as regard age, sex, BMI, and liver function tests
(ALT and AST).
There was an increase in the plasma glucose level in the
immediate postoperative period and in the 24 h postoperative
results in both groups (P value < 0.05) as compared with
the preoperative values. But there was more increase in the
plasma glucose level in the control group compared to the glu-
tamine group (P value < 0.05). However, as regard the plasma
insulin level, there was no signiﬁcant difference in each group
or between the two groups (Table 2).
There was an increase in insulin resistance as indicated by
increased HOMA-IR test in both groups in the immediate
and in the 24 h postoperative samples (P value < 0.05) as
compared with the preoperative value. But there was a signif-
icant increase in HOMA-IR test values in the control group as
compared to the glutamine group in both postoperative sam-
ples (P value < 0.05) (Table 2, Fig. 1).
There were no signiﬁcant differences in preoperative plasma
glutathione levels between the two groups. However, immedi-
Table 2 Plasma glucose and insulin levels in the two groups.
Control group Glutamine group
Preoperative Immediately postoperative 24 h Postoperative Preoperative Immediately postoperative 24 h Postoperative
Glucose (mg/dL) 80.00 ± 4.99 95.10 ± 9.34* 108.95 ± 8.38* 81.80 ± 5.74 89.15 ± 7.27*, 97.70 ± 6.51*,
Insulin (IU/mL) 10.20 ± 0.72 10.19 ± 0.88 9.92 ± 0.43 9.93 ± 0.48 9.89 ± 0.37 9.90 ± 0.50
HOMA-IR 2.01 ± 0.18 2.40 ± 0.34* 2.67 ± 0.24* 2.00 ± 0.01 2.17 ± 0.16*, 2.39 ± 0.18,
Data presented as mean ± SD.
HOMA-IR, homeostasis model assessment – insulin resistance.
 P value < 0.05 is considered signiﬁcant as regard to control group.
* P value < 0.05 is considered signiﬁcant as regard to preoperative value within the same group.
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levels were signiﬁcantly higher (P= 0.047 and 0.003, respec-
tively) in the glutamine group compared to the control group.
But there was no signiﬁcance difference within each group
(Table 3).
Serum albumin at induction of anesthesia was normal in
the two groups and declined non signiﬁcantly in the immediate
postoperative period, but 24 h postoperatively the serum albu-
min declined signiﬁcantly in control group (P= 0.00)
(Table 3).
There was a slightly increasing trend of AST and ALT in
both groups postoperatively but not statistically signiﬁcant.
There were no statistically signiﬁcant changes in the plasma so-
dium and potassium levels in both groups at any tested time
points postoperatively (Table 4).0
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Figure 1 HOMA-IR in the two groups.
Table 3 Plasma glutathione and albumin levels in the two groups.
Control group
Preoperative Immediately postoperative 24 h Post
Glutathione (lmol/L) 6.44 ± 2.10 4.70 ± 1.50 4.80 ± 1.
Albumin (g/dL) 3.5 ± 0.10 3.4 ± 0.90 3.3 ± 0.
Data presented as mean ± SD.
 P value < 0.05 is considered signiﬁcant as regard to control group.
* P value < 0.05 is considered signiﬁcant as regard to preoperative value4. Discussion
We have tested the inﬂuence of preoperative IV alanyl-gluta-
mine on insulin resistant state and hyperglycemia in the early
postoperative patients. We found that in cancer patients pre-
sented for abdominal or pelvic surgery; insulin resistance and
glucose level were less in two tested postoperative time points
in the treated group. Furthermore, an important ﬁnding of our
study was the preservation of glutathione serum level in the
glutamine group of patients as compared to the control group.
We hypothesized that the preserved insulin sensitivity in glu-
tamine group in our study might be due to interruption of the
preoperative fasting state by glutamine in addition to the inher-
ent effects of glutamine in this regards. Preoperative intake of a
standardized nutrients through enteral or parenteral routes in
order to break the overnight fasted catabolic state and set day-
time anabolic metabolism before surgical stress has been tried
[3,19]. The basal rate of insulin secretion is 0.4–0.7 U/h, increas-
ing rapidly by 4- to 5-fold after ingestion of food [8]. Preoper-
ative Carbohydrate Therapy (PCT) has been tried. PCT
improved postoperative insulin sensitivity due to better preser-
vation of the insulin signaling pathways for the major anabolic
effects in muscle cells. A more recent explanation is preventing
excessive incomplete mitochondrial b-oxidation, characterized
by perturbed carnitine metabolism [20].
It is not known exactly how does glutamine act on insulin
sensitivity, and it is currently under investigation. Glutamine
has been found to preserve insulin sensitivity in animal studies.
In canines, it has been shown that glutamine decreased insu-
lin’s action on glucose production and increased its effect on
glucose utilization [21]. In rats, glutamine improved liver and
peripheral insulin sensitivity. It was suggested that glutamine
inﬂuences glucose and fat metabolism by reducing proinﬂam-
matory pathways through the observed decreased TNF-a
production [22].Glutamine group
operative Preoperative Immediately postoperative 24 h Postoperative
45 6.50 ± 1.80 5.64 ± 1.39 6.30 ± 1.50
05* 3.5 ± 0.08 3.5 ± 0.01 3.4 ± 0.90
within the same group.
Table 4 Other biochemical reading.
Control group Glutamine group
Preoperative Immediately postoperative 24 h Postoperative Preoperative Immediately postoperative 24 h Postoperative
AST U/L 18.5 ± 3.4 18.6 ± 2.4 18.9 ± 3.5 17.4 ± 3.3 18.3 ± 3.1 18.5 ± 3.3
ALT U/L 17.2 ± 2.2 17.5 ± 2.3 17.6 ± 3.1 16.6 ± 3.1 16.9 ± 2.2 17.2 ± 2.5
Na mEq/L 130 ± 12 128 ± 11 129 ± 10 132 ± 12 130 ± 15 129 ± 12
K mEq/L 3.3 ± 0.2 3.3 ± 0.1 3.2 ± 0.2 3.4 ± 0.2 3.3 ± 0.3 3.3 ± 0.1
Data presented as mean ± SD.
AST, aspartate aminotransferase; ALT, alanine aminotransferase; Na, sodium; K, potassium.
\P value < 0.05 is considered signiﬁcant.
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the oxidative stress which contributes to tissue injury. During
surgical stress, plasma glutathione levels normally decrease
[23]. Our current study proved that glutathione levels were
higher in the glutamine treated group than control. Glutathi-
one is normally present within the cell in a reduced (GSH)
and an oxidized form (GSSG). The ratio of GSH:GSSG is
the most important regulator of the cellular redox potential
[13]. It is also a potent anti-oxidant as well. The redox poten-
tial inﬂuences the cellular capability to scavenge free radicals
derived from oxygen and also inﬂuences several intracellular
mechanisms [23].
Only few studies used pharmaconutrition concept or gluta-
mine in this context. Bakalar and colleagues examined the
inﬂuence of parenteral nutrition enriched with alanyl-
glutamine in a dosage of 0.4 g/kg/day on insulin resistance in
multiple-trauma patients. They showed that insulin resistance
worsens with standard nutritional formula during the ﬁrst
week of critical illness, but glutamine supplementation was
able to prevent this worsening [24]. Hissa et al. tried to identify
the effects of alanyl-glutamine infusion during the operative
period, upon blood lactate and glucose concentrations in car-
diac surgery patients. They observed a signiﬁcant decrease in
glucose level during the intraoperative period in alanyl-gluta-
mine treated patients compared with saline-treated patients.
They proposed this difference to be due to the ability of gluta-
mine to reduce insulin resistance without actually measuring
insulin resistance [25]. Similarly, Cunha Filho and colleagues
used alanyl-glutamine infusion in children submitted to elec-
tive cleft lip and palate repair. They compared the following
variables at ﬁve different time points: glutathione, thiobarbitu-
ric acid reactive substances, glucose, insulin, C-reactive pro-
tein, and interleukin-6. They observed a better glycemic
control in alanyl-glutamine group as compared with the con-
trol group [26]. In a recent study, Dock-Nascimento et al.
found that a shortened preoperative fast with glutamine plus
a carbohydrate based beverage improved insulin resistance
and antioxidant defenses and decreases the inﬂammatory re-
sponse after video-cholecystectomy [27].
We concluded that preoperative IV alanyl-glutamine is
helpful in amelioration of insulin resistance and improvement
of plasma glutathione levels in the early postoperative period.
Our results support the use of alanyl-glutamine as a preopera-
tive metabolic preconditioning medication. Further larger re-
searches with different concentrations of glutamine are
needed to elucidate and conﬁrm our ﬁndings. More frequent
intraoperative and postoperative measurements may be moreinformative. Also, late measurement of glycosylated hemoglo-
bin may provide us with valuable results.
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